Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,509Revenue (TTM) $M909Net Margin (%)-6.1Altman Z-Score2.7
Enterprise Value $M1,802EPS (TTM) $-1.1Operating Margin %-4.8Piotroski F-Score5
P/E(ttm)--Beneish M-Score-3.0Pre-tax Margin (%)-5.9Higher ROA y-yN
Price/Book2.110-y EBITDA Growth Rate %-2.8Quick Ratio1.6Cash flow > EarningsY
Price/Sales1.75-y EBITDA Growth Rate %-16.8Current Ratio2.6Lower Leverage y-yY
Price/Free Cash Flow76.6y-y EBITDA Growth Rate %-62.8ROA % (ttm)-4.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-7.2Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M51.0ROIC % (ttm)-4.6Gross Margin Increase y-yN

Gurus Latest Trades with HAE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HAEBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Sold Out -0.09%$29.84 - $34.98
($32.25)
$ 29.57-8%Sold Out0
HAEKen Fisher 2016-03-31 Add$29.84 - $34.98
($32.25)
$ 29.57-8%Add 0.01%219,127
HAEBarrow, Hanley, Mewhinney & Strauss 2015-12-31 Reduce-0.02%$30.85 - $34.37
($32.41)
$ 29.57-9%Reduce -17.64%1,844,774
HAEKen Fisher 2015-12-31 Add$30.85 - $34.37
($32.43)
$ 29.57-9%Add 4.88%219,110
HAEBarrow, Hanley, Mewhinney & Strauss 2015-09-30 Reduce-0.01%$32.32 - $41.05
($37.68)
$ 29.57-22%Reduce -4.12%2,239,841
HAEJoel Greenblatt 2015-09-30 Sold Out -0.01%$32.32 - $41.05
($37.68)
$ 29.57-22%Sold Out0
HAEKen Fisher 2015-09-30 Add$32.32 - $41.05
($37.68)
$ 29.57-22%Add 10.24%208,920
HAEJoel Greenblatt 2015-06-30 Add0.01%$40.11 - $44.93
($42.2)
$ 29.57-30%Add 369.65%35,271
HAEBarrow, Hanley, Mewhinney & Strauss 2015-06-30 Reduce$40.11 - $44.93
($42.2)
$ 29.57-30%Reduce -0.42%2,336,063
HAEKen Fisher 2015-06-30 Reduce$40.11 - $44.93
($42.2)
$ 29.57-30%Reduce -2.43%189,520
HAEJoel Greenblatt 2015-03-31 Buy $36.92 - $45.38
($41.8)
$ 29.57-29%New holding7,510
HAEBarrow, Hanley, Mewhinney & Strauss 2015-03-31 Reduce$36.92 - $45.38
($41.8)
$ 29.57-29%Reduce -0.12%2,345,971
HAEJoel Greenblatt 2014-12-31 Sold Out -0.01%$34.15 - $38.88
($36.69)
$ 29.57-19%Sold Out0
HAEJoel Greenblatt 2014-09-30 Reduce$34.1 - $37.1
($35.69)
$ 29.57-17%Reduce -23.47%29,531
HAERobert Olstein 2014-06-30 Sold Out -0.06%$30.36 - $35.62
($33.37)
$ 29.57-11%Sold Out0
HAEFirst Eagle Investment 2014-06-30 Sold Out -0.0009%$30.36 - $35.62
($33.41)
$ 29.57-11%Sold Out0
HAEKen Fisher 2014-06-30 Add$30.36 - $35.62
($33.37)
$ 29.57-11%Add 20.48%177,645
HAEBarrow, Hanley, Mewhinney & Strauss 2014-03-31 Add0.1%$31.84 - $43.37
($38.44)
$ 29.57-23%Add 217.54%3,042,669
HAERobert Olstein 2014-03-31 Buy 0.06%$31.84 - $43.37
($38.44)
$ 29.57-23%New holding14,400
HAEJoel Greenblatt 2014-03-31 Buy 0.02%$31.84 - $43.37
($38.44)
$ 29.57-23%New holding42,809
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HAE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


HAE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Selman ByronPresident, Global Markets 2015-10-26Sell344$32.13-7.97view
White JonathanChief Science and Technology 2015-10-26Sell319$32.13-7.97view
Jesse SandraEVP and Chief Legal Officer 2015-10-26Sell778$32.13-7.97view
HANLON SUSAN MVP Finance 2015-10-26Sell497$32.13-7.97view
LINDOP CHRISTOPHER JCFO & EVP Business Development 2015-10-26Sell436$32.13-7.97view
Davies Kent JCOO 2015-10-23Sell278$31.75-6.87view
Selman ByronPresident, Global Markets 2015-10-23Sell191$31.75-6.87view
Jesse SandraEVP and Chief Legal Officer 2015-10-23Sell250$31.75-6.87view
White JonathanChief Science and Technology 2015-10-23Sell250$31.75-6.87view
HANLON SUSAN MVP Finance 2015-10-23Sell162$31.75-6.87view

Quarterly/Annual Reports about HAE:

News about HAE:

Articles On GuruFocus.com
DENTSPLY´s Growth Opportunities Dec 16 2014 
Meridian Contrarian Fund Second Quarter Commentary Sep 08 2014 
Guru Held Stocks Near Historical Low P/B Jul 22 2014 
The Olstein All Cap Value Fund’s 2014 First Quarter Letter to Shareholders Jul 22 2014 
This Blood Management Company Can Be A Safe Investment Jul 13 2014 
Meridian Funds Comments on Haemonetics Aug 28 2013 
Meridian Funds' Second Quarter 2013 Commentary Aug 28 2013 
Weeky CFO Sells Highlight: ADBE, HAE, WAGE, OVTI, ICPT Jun 24 2013 
Allscripts-Misys Reports 5 Insider Buys the Day Before Barclays Conference Mar 13 2013 
Weekly Guru Bargains Highlights: HAE, DLTR, QCOR, MTX, AMD Jan 21 2013 

More From Other Websites
Haemonetics Sets Date for 1st Quarter Fiscal 2017 Earnings Release: August 1, 2016 Jul 18 2016
HAEMONETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers Jul 06 2016
Haemonetics Corp. – Value Analysis (NYSE:HAE) : July 5, 2016 Jul 05 2016
Haemonetics Corp. breached its 50 day moving average in a Bullish Manner : HAE-US : July 1, 2016 Jul 01 2016
Haemonetics Corp. breached its 50 day moving average in a Bullish Manner : HAE-US : June 21, 2016 Jun 21 2016
ETF’s with exposure to Haemonetics Corp. : June 20, 2016 Jun 20 2016
Haemonetics: Q4 Hit by Issues in Russia, Currency Woes Stay Jun 09 2016
HAEMONETICS CORP Financials Jun 07 2016
HAEMONETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers Jun 06 2016
HAEMONETICS CORP Files SEC form 10-K, Annual Report Jun 01 2016
Invetech, Haemonetics, and Coramed Technologies Receive 2016 Good Design Award® for Development of... Jun 01 2016
Invetech, Haemonetics, and Coramed Technologies Receive 2016 Good Design Award® for Development of... Jun 01 2016
Q1 2016: Sales growth 50% to EUR 67.94 million, EBIT-growth 100% to EUR 3.47 million,compared to... May 26 2016
Haemonetics to Present at Jefferies 2016 Healthcare Conference May 26 2016
Haemonetics to Present at Jefferies 2016 Healthcare Conference May 26 2016
2015: Preliminary IFRS results May 26 2016
Q1 2016: Sales growth 50% to EUR 67.94 million, EBIT-growth 100% to EUR 3.47 million, compared to... May 26 2016
Haemonetics upgraded by Goldman May 16 2016
HAEMONETICS CORP Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in... May 10 2016
Haemonetics Provides Fiscal 2017 Guidance May 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)